Congestive heart failure is a major health problem that afflicts close to 1.5% of the population of the US and Canada. Patients with congestive heart failure have significantly reduced survival and quality of life. Multiple new strategies for the treatment of congestive heart failure are being developed, many of them involving complex strategies, including some that hope to regenerate the heart. Progress in transforming these treatment strategies from ideas to clinical practice is hampered by a lack of a network of sophisticated clinical researchers possessing the infrastructure required to test these complex strategies. The NIH has decided to form a Heart Failure Research Network of to address this challenge. The Canadian East-West Network is proposing to join the NIH Network to help it attain its goals of bringing innovative experimental strategies for the treatment of heart failure from the laboratory to the bedside. The Canadian East-West Network is made up of 19 university hospital centers, 7 large regional hospital centers, and 18 regional hospital centers. Together they treat over 10,000 patients with heart failure, of which around 25% are new patients a year. Their university hospital centers have the sole tertiary responsibility for 13.5 million people, and share in the tertiary care responsibility of another 10 million people. All major hospitals caring for the 8 million people in the province of Quebec take part in the Network. The Canadian East-West Network has a number of special attributes, and brings with it expertise that would be helpful to the NIH network as a whole. Its members belong to a single payer socialized medical system, which facilitates patient follow-up and data generation. It has a long and successful tradition of working with the NIH, it has an experienced clinical research coordinating center, and some of its members have worked successfully as a network for nearly twenty years. The Canadian East-West Network brings with it a web-based electronic patient record that it has developed and is willing to share, a cutting edge pharmacogenomics center, expertise in blood sampling, transportation and measurement, and two implantable artificial heart programs. The Canadian East-West Network proposes a project using pharmacogenomics to identify which patients are most and least likely to benefit from a given medication, and a second project that will compare the ability of two types of a patients own stem cells in regenerating their heart after a large myocardial infarction (heart attack).

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-H (M1))
Program Officer
Mascette, Alice
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Montreal Heart Institute
Zip Code
H1 1-C8
AbouEzzeddine, Omar F; McKie, Paul M; Dunlay, Shannon M et al. (2017) Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc 6:
Grodin, Justin L; Sun, Jie-Lena; Anstrom, Kevin J et al. (2017) Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF). Am J Cardiol 119:78-83
AbouEzzeddine, Omar F; Wong, Yee Weng; Mentz, Robert J et al. (2016) Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. J Card Fail 22:853-858
Gandhi, Parul U; Gaggin, Hanna K; Redfield, Margaret M et al. (2016) Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial. JACC Heart Fail 4:860-869
Butler, Javed; Hernandez, Adrian F; Anstrom, Kevin J et al. (2016) Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. JACC Heart Fail 4:726-35
AbouEzzeddine, Omar F; Lala, Anuradha; Khazanie, Prateeti P et al. (2016) Evaluation of a provocative dyspnea severity score in acute heart failure. Am Heart J 172:34-41
Wan, Siu-Hin; Stevens, Susanna R; Borlaug, Barry A et al. (2016) Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circ Heart Fail 9:
Hussain, Imad; Mohammed, Selma F; Forfia, Paul R et al. (2016) Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Circ Heart Fail 9:e002729
Vader, Justin M; LaRue, Shane J; Stevens, Susanna R et al. (2016) Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials. J Card Fail 22:875-883
Redfield, Margaret M; Anstrom, Kevin J; Levine, James A et al. (2015) Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. N Engl J Med 373:2314-24

Showing the most recent 10 out of 22 publications